Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction.
Use of the angiogenic biomarker profile to risk stratify patients with fetal growth restriction. Am J Obstet Gynecol MFM. 2021 07; 3(4):100394.
View in:
PubMed
subject areas
Biomarkers
Female
Fetal Growth Retardation
Humans
Infant
Infant, Newborn
Placenta Growth Factor
Pregnancy
Prospective Studies
Vascular Endothelial Growth Factor Receptor-1
authors with profiles
Sarosh Rana
Jacques Abramowicz
Kiang-Teck Jerry Yeo
Joana Lopes Perdigao